Your browser doesn't support javascript.
loading
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
De Filippo, Ovidio; D'Ascenzo, Fabrizio; Wanha, Wojciech; Leonardi, Sergio; Raposeiras Roubin, Sergio; Fabris, Enrico; Truffa Giachet, Alessandra; Huczek, Zenon; Gaibazzi, Nicola; Ielasi, Alfonso; Cortese, Bernardo; Borin, Andrea; Núñez-Gil, Iván J; Ugo, Fabrizio; Marengo, Giorgio; Bianco, Matteo; Barbieri, Lucia; Marchini, Federico; Desperak, Piotr; Melendo-Viu, María; Montalto, Claudio; Bruno, Francesco; Mancone, Massimo; Ferrandez-Escarabajal, Marcos; Morici, Nuccia; Scaglione, Marco; Tuttolomondo, Domenico; Gasior, Mariusz; Mazurek, Maciej; Gallone, Gugliemo; Campo, Gianluca; Wojakowski, Wojciech; Abu Assi, Emad; Sinagra, Gianfranco; de Ferrari, Gaetano Maria.
Afiliación
  • De Filippo O; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
  • D'Ascenzo F; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: fabrizio.dascenzo@unito.it.
  • Wanha W; Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Leonardi S; Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Italy.
  • Raposeiras Roubin S; Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
  • Fabris E; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
  • Truffa Giachet A; Division of Cardiology, Ospedale Cardinal G. Massaia, Asti, Italy.
  • Huczek Z; 1st Department of Cardiology, Medical University of Warsaw, Warszawa, Poland.
  • Gaibazzi N; Cardiology Department, Parma University Hospital, Parma, Italy.
  • Ielasi A; U.O. di Cardiologia Clinica ed Interventistica, Istituto Clinico Sant'Ambrogio, Milan, Italy.
  • Cortese B; Cardiovascular Research Team, San Carlo Clinic, Milano, Italy; Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy.
  • Borin A; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
  • Núñez-Gil IJ; Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain.
  • Ugo F; Division of Cardiology, Sant'Andrea Hospital, Vercelli, Italy.
  • Marengo G; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
  • Bianco M; Division of Cardiology, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.
  • Barbieri L; Division of Cardiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; University of Milan, Milan, Italy.
  • Marchini F; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
  • Desperak P; Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Melendo-Viu M; Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
  • Montalto C; Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Italy.
  • Bruno F; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
  • Mancone M; Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma; 1st Department of Cardiology, Medical University of Warsaw, Warszawa, Poland.
  • Ferrandez-Escarabajal M; Cardiovascular Institute, Hospital Clinico San Carlos, Madrid, Spain.
  • Morici N; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Scaglione M; Division of Cardiology, Ospedale Cardinal G. Massaia, Asti, Italy.
  • Tuttolomondo D; Cardiology Department, Parma University Hospital, Parma, Italy.
  • Gasior M; Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Mazurek M; Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma; 1st Department of Cardiology, Medical University of Warsaw, Warszawa, Poland.
  • Gallone G; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Campo G; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
  • Wojakowski W; Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Abu Assi E; Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
  • Sinagra G; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
  • de Ferrari GM; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy.
Int J Cardiol ; 370: 35-42, 2023 01 01.
Article en En | MEDLINE | ID: mdl-36306949
ABSTRACT

BACKGROUND:

Previous studies investigating predictors of Heart Failure (HF) after acute coronary syndrome (ACS) were mostly conducted during fibrinolytic era or restricted to baseline characteristics and diagnoses prior to admission. We assessed the incidence and predictors of HF hospitalizations among patients treated with percutaneous coronary intervention (PCI) for ACS. METHODS AND

RESULTS:

CORALYS is a multicenter, retrospective, observational registry including consecutive patients treated with PCI for ACS. Patients with known history of HF or reduced left ventricular ejection fraction (LVEF) were excluded. Incidence of HF hospitalizations was the primary endpoint. The composite of HF hospitalization or cardiovascular death, and cardiovascular and all-cause death were the secondary endpoints. Predictors of HF hospitalizations and the impact of HF hospitalization on cardiovascular and all-cause death were assessed by means of multivariable Cox proportional hazards model.14699 patients were included. After 2.9 ± 1.8 years, the incidence of HF hospitalizations was 12.7%. Multivariable analysis identified age, diabetes, chronic kidney disease, previous myocardial infarction, atrial fibrillation, pulmonary disease, GRACE risk-score ≥ 141, peripheral artery disease, cardiogenic shock at admission and LVEF ≤40% as independently associated with HF hospitalizations. Complete revascularization was associated with a lower risk of HF (HR 0.46,95%CI 0.39-0.55). HF hospitalization was associated with higher risk of CV and all-cause death (HR 1.89,95%CI 1.5-2.39 and HR 1.85,95%CI 1.6-2.14, respectively).

CONCLUSIONS:

Incidence of HF hospitalizations among patients treated with PCI for ACS is not negligible and is associated with detrimental impact on patients' prognosis. Several variables may help to assess the risk of HF after ACS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Italia